期刊文献+

新型纳米结构脂质载体系统的研究进展 被引量:24

Development on novel nanostructured lipid carriers
下载PDF
导出
摘要 目的介绍新型的纳米结构脂质载体系统的研究进展,为其研究和应用提供参考。方法查阅相关文献33篇,进行整理和归纳。结果新型的纳米结构脂质载体能够克服固体脂质纳米粒的一些不足,并具有独特的结构特征,药物的包封机理和释放特征。结论纳米结构脂质载体作为药物传递系统的一种新剂型,具有广阔的发展前景。 Objective To review the study on novel nanostructured lipid carriers (NLC) and provide a reference for the further research and development of NLC. Methods The structure features, production methods, stability, drug incorporation and drug release mechanisms, application of NLC were introduced on the basis of related references. Results Novel NLC could overcome the potential drawbacks of solid lipid nanoparticles (SLN) and possess the particular structure features, drug incorporation mechanisms and drug release characters. Conclusions As a new dosage form of drug delivery systems, NLC has an exciting prospect in pharmaceutics.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2008年第3期236-242,共7页 Journal of Shenyang Pharmaceutical University
关键词 纳米结构脂质载体 固体脂质纳米粒 结构特征 包封 释放 应用 nanostructured lipid carriers solid lipid nanoparticles structure features incorporation release application
  • 相关文献

参考文献2

二级参考文献13

  • 1李珺婵,方晓玲,沙先谊,吴云娟,张丽珺.9-硝基喜树碱半固体脂质纳米粒的制备及大鼠的药动学研究[J].中国医药工业杂志,2004,35(10):599-602. 被引量:14
  • 2Dancey J, Eisenhauer EA. Current perspectives on camptothecins in cancer teatment [J]. Br J Cancer, 1996, 74(3): 327-338. 被引量:3
  • 3Sands H, Mishra A, StoecKler JD, et al. Preclinical activity of an i.v. formulation of rubitecan in IDD-PTM against human solid tumor xenografts [J]. Anti-Cancer Drugs, 2002, 13 (9):965-975. 被引量:1
  • 4Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm, 2002, 242(1-2) : 121-128. 被引量:2
  • 5Maller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [ J ].Iht J Pharm, 2002,242( 1 - 2 ): 121 - 128. 被引量:1
  • 6Dancey J, Eisenhauer EA. Current perspectives on camptothecins in cancer treatment [ J ]. Br Jr 443/Cancer, 1996,74:327. 被引量:1
  • 7Giovanella BC, Stehlin JS, Hinz HR, et al. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro20 ( S)-camptotheein (Rubitecan) [ J ]. Int J Oncol,2001,20:81 - 88. 被引量:1
  • 8Knight JV, Gilbert B, Waldrep JC, et al. Composition for treating cancer via liposomal aerosol formulation containing taxol [ P]. US Pat: 6346233, 2002-02-12. 被引量:1
  • 9Sands H, Mishra A, Stoeckler JD, et al. Preclinical activity of an i. v. formulation of rubitecan in IDD-PTM against human solid tumor xenografts [ J ]. Anticancer Drugs, 2002,13(9) :965. 被引量:1
  • 10王杰,张强,索中军,陈大兵,魏树礼.PEG表面修饰硬脂酸脂质纳米粒的制备与体外细胞摄取[J].药学学报,2000,35(8):622-625. 被引量:15

共引文献29

同被引文献305

引证文献24

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部